Abstract
The zinc-dependent metalloprotease anthrax lethal factor (LF) is the enzymatic component of a toxin thought to have a major role in Bacillus anthracis infections. Like many bacterial toxins, LF is a secreted protein that functions within host cells. LF is a highly selective protease that cleaves a limited number of substrates in a site-specific manner, thereby impacting host signal transduction pathways. The major substrates of LF are mitogen-activated protein kinase kinases (MKKs), which lie in the middle of three-component phosphorylation cascades mediating numerous functions in a variety of cells and tissues. How LF targets its limited substrate repertoire has been an active area of investigation. LF recognizes a specific sequence motif surrounding the scissile bonds of substrate proteins. X-ray crystallography of the protease in complex with peptide substrates has revealed the structural basis of selectivity for the LF cleavage site motif. In addition to having interactions proximal to the cleavage site, LF binds directly to a more distal region in its substrates through a so-called exosite interaction. This exosite has been mapped to a surface within a non-catalytic domain of LF with previously unknown function. A putative LF-binding site has likewise been identified on the catalytic domains of MKKs. Here we review our current state of understanding of LF-substrate interactions and discuss the implications for the design and discovery of inhibitors that may have utility as anthrax therapeutics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AC:
-
Adenylyl cyclase
- BoNT:
-
Botulinum neurotoxin
- cAMP:
-
Cyclic AMP
- EdTx:
-
Edema toxin
- EF:
-
Edema factor
- HTS:
-
High-throughput screening
- LeTx:
-
Lethal toxin
- LF:
-
Anthrax lethal factor
- MAPK:
-
Mitogen-activated protein kinase
- MKK:
-
Mitogen-activated protein kinase kinase
- NLRP:
-
NACHT domain, leucine rich repeat and pyrin domain containing protein
- NOS1:
-
Constitutive nitric oxide synthase
- PA:
-
Protective antigen
- PAMP:
-
Pathogen-associated molecular pattern
References
Abrami L, Reig N, van der Goot FG (2005) Anthrax toxin: the long and winding road that leads to the kill. Trends Microbiol 13(2):72–78
Agrawal A, Lingappa J, Leppla SH, Agrawal S, Jabbar A, Quinn C, Pulendran B (2003) Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424(6946):329–334
Arora N, Leppla SH (1993) Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J Biol Chem 268(5):3334–3341
Atwal JK, Chen Y, Chiu C, Mortensen DL, Meilandt WJ, Liu Y, Heise CE, Hoyte K, Luk W, Lu Y, Peng K, Wu P, Rouge L, Zhang Y, Lazarus RA, Scearce-Levie K, Wang W, Wu Y, Tessier-Lavigne M, Watts RJ (2011) A therapeutic antibody targeting BACE1 inhibits amyloid-beta production in vivo. Sci Transl Med 3(84):84ra43
Baldari CT, Tonello F, Paccani SR, Montecucco C (2006) Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol 27(9):434–440
Bannwarth L, Goldberg AB, Chen C, Turk BE (2012) Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening. Chem Biol 19(7):875–882
Bardwell AJ, Abdollahi M, Bardwell L (2004) Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs. Biochem J 378(Pt 2):569–577
Biondi RM, Nebreda AR (2003) Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem J 372 .(Pt 1:1–13
Bjorklund M, Heikkila P, Koivunen E (2004) Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion. J Biol Chem 279(28):29589–29597
Boyden ED, Dietrich WF (2006) Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 38(2):240–244
Cafardi V, Biagini M, Martinelli M, Leuzzi R, Rubino JT, Cantini F, Norais N, Scarselli M, Serruto D, Unnikrishnan M (2013) Identification of a novel zinc metalloprotease through a global analysis of Clostridium difficile extracellular proteins. PLoS One 8(11):e81306
Cerda-Costa N, Gomis-Ruth FX (2014) Architecture and function of metallopeptidase catalytic domains. Protein Sci 23(2):123–144
Chavarria-Smith J, Vance RE (2013) Direct proteolytic cleavage of NLRP1B is necessary and sufficient for inflammasome activation by anthrax lethal factor. PLoS Pathog 9(6):e1003452
Chavarria-Smith J, Mitchell PS, Ho AM, Daugherty MD, Vance RE (2016) Functional and evolutionary analyses identify proteolysis as a general mechanism for NLRP1 inflammasome activation. PLoS Pathog 12(12):e1006052
Chopra AP, Boone SA, Liang X, Duesbery NS (2003) Anthrax lethal factor proteolysis and inactivation of MAPK kinase. J Biol Chem 278(11):9402–9406
Crawford MA, Aylott CV, Bourdeau RW, Bokoch GM (2006) Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J Immunol 176(12):7557–7565
Cybulski RJ Jr, Sanz P, O'Brien AD (2009) Anthrax vaccination strategies. Mol Asp Med 30(6):490–502
Dennis MS, Eigenbrot C, Skelton NJ, Ultsch MH, Santell L, Dwyer MA, O’Connell MP, Lazarus RA (2000) Peptide exosite inhibitors of factor VIIa as anticoagulants. Nature 404(6777):465–470
Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD, Ahn NG, Oskarsson MK, Fukasawa K, Paull KD, Vande Woude GF (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280(5364):734–737
During RL, Li W, Hao B, Koenig JM, Stephens DS, Quinn CP, Southwick FS (2005) Anthrax lethal toxin paralyzes neutrophil actin-based motility. J Infect Dis 192(5):837–845
Fink SL, Bergsbaken T, Cookson BT (2008) Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc Natl Acad Sci U S A 105(11):4312–4317
Firoved AM, Miller GF, Moayeri M, Kakkar R, Shen Y, Wiggins JF, McNally EM, Tang WJ, Leppla SH (2005) Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol 167(5):1309–1320
Friedlander AM (1986) Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem 261(16):7123–7126
Goldberg AB, Turk BE (2016) Inhibitors of the metalloproteinase anthrax lethal factor. Curr Top Med Chem 16(21):2350–2358
Goldberg AB, Cho E, Miller CJ, Lou HJ, Turk BE (2017) Identification of a substrate-selective exosite within the metalloproteinase anthrax lethal factor. J Biol Chem 292(3):814–825
Grubbs KJ, Bleich RM, Santa Maria KC, Allen SE, Farag S, AgBiome T, Shank EA, Bowers AA (2017) Large-scale bioinformatics analysis of Bacillus genomes uncovers conserved roles of natural products in bacterial physiology. mSystems 2(6):e00040
Haling JR, Sudhamsu J, Yen I, Sideris S, Sandoval W, Phung W, Bravo BJ, Giannetti AM, Peck A, Masselot A, Morales T, Smith D, Brandhuber BJ, Hymowitz SG, Malek S (2014) Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signaling. Cancer Cell 26(3):402–413
Hellmich KA, Levinsohn JL, Fattah R, Newman ZL, Maier N, Sastalla I, Liu S, Leppla SH, Moayeri M (2012) Anthrax lethal factor cleaves mouse Nlrp1b in both toxin-sensitive and toxin-resistant macrophages. PLoS One 7(11):e49741
Jiao GS, Kim S, Moayeri M, Cregar-Hernandez L, McKasson L, Margosiak SA, Leppla SH, Johnson AT (2010) Antidotes to anthrax lethal factor intoxication. Part 1: discovery of potent lethal factor inhibitors with in vivo efficacy. Bioorg Med Chem Lett 20(22):6850–6853
Jiao GS, Kim S, Moayeri M, Crown D, Thai A, Cregar-Hernandez L, McKasson L, Sankaran B, Lehrer A, Wong T, Johns L, Margosiak SA, Leppla SH, Johnson AT (2012) Antidotes to anthrax lethal factor intoxication. Part 3: evaluation of core structures and further modifications to the C2-side chain. Bioorg Med Chem Lett 22(6):2242–2246
Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298(5600):1911–1912
Julien O, Wells JA (2017) Caspases and their substrates. Cell Death Differ 24(8):1380–1389
Kandadi MR, Hua Y, Ma H, Li Q, Kuo SR, Frankel AE, Ren J (2010) Anthrax lethal toxin suppresses murine cardiomyocyte contractile function and intracellular Ca2+ handling via a NADPH oxidase-dependent mechanism. PLoS One 5(10):e13335
Kim J, Park H, Myung-Hyun J, Han SH, Chung H, Lee JS, Park JS, Yoon MY (2008) The effects of anthrax lethal factor on the macrophage proteome: potential activity on nitric oxide synthases. Arch Biochem Biophys 472(1):58–64
Kim S, Jiao GS, Moayeri M, Crown D, Cregar-Hernandez L, McKasson L, Margosiak SA, Leppla SH, Johnson AT (2011) Antidotes to anthrax lethal factor intoxication. Part 2: structural modifications leading to improved in vivo efficacy. Bioorg Med Chem Lett 21(7):2030–2033
Klein F, Hodges DR, Mahlandt BG, Jones WI, Haines BW, Lincoln RE (1962) Anthrax toxin: causative agent in the death of rhesus monkeys. Science 138:1331–1333
Krachler AM, Woolery AR, Orth K (2011) Manipulation of kinase signaling by bacterial pathogens. J Cell Biol 195(7):1083–1092
Lee CS, Dykema KJ, Hawkins DM, Cherba DM, Webb CP, Furge KA, Duesbery NS (2011) MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells. PLoS One 6(2):e17165
Levinsohn JL, Newman ZL, Hellmich KA, Fattah R, Getz MA, Liu S, Sastalla I, Leppla SH, Moayeri M (2012) Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog 8(3):e1002638
Li H, Xu H, Zhou Y, Zhang J, Long C, Li S, Chen S, Zhou JM, Shao F (2007) The phosphothreonine lyase activity of a bacterial type III effector family. Science 315(5814):1000–1003
Li F, Terzyan S, Tang J (2011) Subsite specificity of anthrax lethal factor and its implications for inhibitor development. Biochem Biophys Res Commun 407(2):400–405
Liang X, Young JJ, Boone SA, Waugh DS, Duesbery NS (2004) Involvement of domain II in toxicity of anthrax lethal factor. J Biol Chem 279(50):52473–52478
Liu S, Crown D, Miller-Randolph S, Moayeri M, Wang H, Hu H, Morley T, Leppla SH (2009) Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc Natl Acad Sci U S A 106(30):12424–12429
Liu S, Miller-Randolph S, Crown D, Moayeri M, Sastalla I, Okugawa S, Leppla SH (2010) Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe 8(5):455–462
Liu S, Zhang Y, Moayeri M, Liu J, Crown D, Fattah RJ, Wein AN, Yu ZX, Finkel T, Leppla SH (2013) Key tissue targets responsible for anthrax-toxin-induced lethality. Nature 501(7465):63–68
Maize KM, Kurbanov EK, De L, Mora-Rey T, Geders TW, Hwang DJ, Walters MA, Johnson RL, Amin EA, Finzel BC (2014) Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding. Acta Crystallogr D Biol Crystallogr 70. (Pt 11:2813–2822
Maize KM, Kurbanov EK, Johnson RL, Amin EA, Finzel BC (2015) Ligand-induced expansion of the S1' site in the anthrax toxin lethal factor. FEBS Lett 589(24 Pt B):3836–3841
Moayeri M, Leppla SH (2009) Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Asp Med 30(6):439–455
Moayeri M, Martinez NW, Wiggins J, Young HA, Leppla SH (2004) Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect Immun 72(8):4439–4447
Moayeri M, Crown D, Dorward DW, Gardner D, Ward JM, Li Y, Cui X, Eichacker P, Leppla SH (2009) The heart is an early target of anthrax lethal toxin in mice: a protective role for neuronal nitric oxide synthase (nNOS). PLoS Pathog 5(5):e1000456
Mock M, Fouet A (2001) Anthrax. Annu Rev Microbiol 55:647–671
Mohamed N, Clagett M, Li J, Jones S, Pincus S, D'Alia G, Nardone L, Babin M, Spitalny G, Casey L (2005) A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge. Infect Immun 73(2):795–802
Newman ZL, Printz MP, Liu S, Crown D, Breen L, Miller-Randolph S, Flodman P, Leppla SH, Moayeri M (2010) Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1. PLoS Pathog 6(5):e1000906
Ngai S, Batty S, Liao KC, Mogridge J (2010) An anthrax lethal factor mutant that is defective at causing pyroptosis retains proapoptotic activity. FEBS J 277(1):119–127
O'Brien J, Friedlander A, Dreier T, Ezzell J, Leppla S (1985) Effects of anthrax toxin components on human neutrophils. Infect Immun 47(1):306–310
Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC (2001) Crystal structure of the anthrax lethal factor. Nature 414(6860):229–233
Paton AW, Beddoe T, Thorpe CM, Whisstock JC, Wilce MC, Rossjohn J, Talbot UM, Paton JC (2006) AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 443(7111):548–552
Pezard C, Berche P, Mock M (1991) Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun 59(10):3472–3477
Pirazzini M, Rossetto O, Eleopra R, Montecucco C (2017) Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev 69(2):200–235
Rawlings ND, Barrett AJ, Thomas PD, Huang X, Bateman A, Finn RD (2018) The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database. Nucleic Acids Res 46(D1):D624–D632
Schacherl M, Pichlo C, Neundorf I, Baumann U (2015) Structural basis of proline-proline peptide bond specificity of the metalloprotease Zmp1 implicated in motility of Clostridium difficile. Structure 23(9):1632–1642
Shoop WL, Xiong Y, Wiltsie J, Woods A, Guo J, Pivnichny JV, Felcetto T, Michael BF, Bansal A, Cummings RT, Cunningham BR, Friedlander AM, Douglas CM, Patel SB, Wisniewski D, Scapin G, Salowe SP, Zaller DM, Chapman KT, Scolnick EM, Schmatz DM, Bartizal K, MacCoss M, Hermes JD (2005) Anthrax lethal factor inhibition. Proc Natl Acad Sci U S A 102(22):7958–7963
Sullivan M, Hornig NC, Porstmann T, Uhlmann F (2004) Studies on substrate recognition by the budding yeast separase. J Biol Chem 279(2):1191–1196
Tang WJ, Guo Q (2009) The adenylyl cyclase activity of anthrax edema factor. Mol Asp Med 30(6):423–430
Thomas G (2002) Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3(10):753–766
Tonello F, Seveso M, Marin O, Mock M, Montecucco C (2002) Screening inhibitors of anthrax lethal factor. Nature 418(6896):386
Tonello F, Naletto L, Romanello V, Dal Molin F, Montecucco C (2004) Tyrosine-728 and glutamic acid-735 are essential for the metalloproteolytic activity of the lethal factor of Bacillus anthracis. Biochem Biophys Res Commun 313(3):496–502
Tournier JN, Quesnel-Hellmann A, Mathieu J, Montecucco C, Tang WJ, Mock M, Vidal DR, Goossens PL (2005) Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol 174(8):4934–4941
Tschopp J, Martinon F, Burns K (2003) NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 4(2):95–104
Turk B (2006) Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov 5(9):785–799
Turk BE (2007) Manipulation of host signalling pathways by anthrax toxins. Biochem J 402(3):405–417
Turk BE, Wong TY, Schwarzenbacher R, Jarrell ET, Leppla SH, Collier RJ, Liddington RC, Cantley LC (2004) The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat Struct Mol Biol 11(1):60–66
Tyndall JDA, Nall T, Fairlie DP (2005) Proteases universally recognize beta strands in their active sites. Chem Rev 105(3):973–999
Vitale G, Pellizzari R, Recchi C, Napolitani G, Mock M, Montecucco C (1998) Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun 248(3):706–711
Vitale G, Bernardi L, Napolitani G, Mock M, Montecucco C (2000) Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J 352(Pt 3):739–745
Watters JW, Dietrich WF (2001) Genetic, physical, and transcript map of the Ltxs1 region of mouse chromosome 11. Genomics 73(2):223–231
Welkos SL, Keener TJ, Gibbs PH (1986) Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun 51(3):795–800
Wright GG, Mandell GL (1986) Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide. J Exp Med 164(5):1700–1709
Wu S, Lim KC, Huang J, Saidi RF, Sears CL (1998) Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci U S A 95(25):14979–14984
Xu Q, Gohler AK, Kosfeld A, Carlton D, Chiu HJ, Klock HE, Knuth MW, Miller MD, Elsliger MA, Deacon AM, Godzik A, Lesley SA, Jahreis K, Wilson IA (2012) The structure of Mlc titration factor A (MtfA/YeeI) reveals a prototypical zinc metallopeptidase related to anthrax lethal factor. J Bacteriol 194(11):2987–2999
Zakharova MY, Kuznetsov NA, Dubiley SA, Kozyr AV, Fedorova OS, Chudakov DM, Knorre DG, Shemyakin IG, Gabibov AG, Kolesnikov AV (2009) Substrate recognition of anthrax lethal factor examined by combinatorial and pre-steady-state kinetic approaches. J Biol Chem 284(27):17902–17913
Acknowledgements
This work was supported by National Institutes of Health grant R01 GM104047.
Conflicts of Interest
The author declares no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Turk, B.E. (2018). Exceptionally Selective Substrate Targeting by the Metalloprotease Anthrax Lethal Factor. In: Atassi, M. (eds) Protein Reviews – Purinergic Receptors. Advances in Experimental Medicine and Biology(), vol 1111. Springer, Cham. https://doi.org/10.1007/5584_2018_273
Download citation
DOI: https://doi.org/10.1007/5584_2018_273
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-14338-1
Online ISBN: 978-3-030-14339-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)